Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of Views

<< 2010 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2012 >>

15 November 2011: Tech City and UCL

Tech City is an extraordinary phenomenon. Hundreds of new digital start-ups emerging in East London creating a dynamic spirit of entrepreneurialism and optimism. It's simply great stuff.
More...

2 November 2011: UCL Enterprise Strategy

Following the publication of the UCL Enterprise Strategy, many people have been struck by the significance of the UCL commitment to supporting the development of 500 new businesses over the next five years.
More...

<< 2010 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2012 >>